Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
2022年6月2日 - 4:32AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For
the month of June 2022
Commission
File Number: 001-40106
4D
pharma plc
(Translation
of Registrant’s name into English)
5th
Floor, 9 Bond Court
Leeds
LS1
2JZ
United
Kingdom
Tel:
+44 (0) 113 895 013
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F
☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Annual
Report and Annual General Meeting
On
May 25, 2022 4D pharma plc (the “Company”) posted the Annual Report for the year ended December 31, 2021 (the “Annual
Report”) and the notice of the Company’s Annual General Meeting (“Notice of AGM”) to shareholders. The AGM will
be held on Tuesday, June 28, 2022 at 9:00 am (British Summer Time) at the offices of Pinsent Masons LLP at 1 Park Row, Leeds, LS1 5AB.
Electronic
copies of both the Annual Report and Notice of AGM can be found on the Company’s website at www.4dpharmaplc.com. Additionally,
a copy of the Annual Report is attached as Exhibit 99.1 to this current report on Form 6-K and is incorporated by reference herein and
a copy of the Notice of AGM is attached as Exhibit 99.2 to this current report on Form 6-K and is incorporated by reference herein
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
4D
pharma plc |
|
|
Date:
June 1, 2022 |
/s/
Duncan Peyton |
|
Duncan
Peyton |
|
Chief
Executive Officer |
Exhibits
4D Pharma (NASDAQ:LBPS)
過去 株価チャート
から 9 2024 まで 10 2024
4D Pharma (NASDAQ:LBPS)
過去 株価チャート
から 10 2023 まで 10 2024